Product Information
AMLODIPINE BESYLATE 5 MG TAB is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0102 per EA under NDC 76282023890. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 28, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282023890
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA077955FDA Approved
8/28/2007
TE Code
AB
On Market Since
11/2/2007
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE BESYLATE 5 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 53.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0102 per EA |
|---|---|
| All-time high | $0.0221 (Feb 12, 2014) |
| All-time low | $0.0095 (Nov 20, 2024) |
| 52-week high | $0.0113 |
| 52-week low | $0.0101 |
| Median price | $0.0128 |
| Average price | $0.0140 |
| Largest weekly change | -22.0% (Dec 20, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine besylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE BESYLATE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE BESYLATE 5 MG TAB, manufactured by Exelan Pharmaceuticals Inc., is $0.0102 per EA (NDC 76282023890), effective Sep 30, 2026.
How has the price of AMLODIPINE BESYLATE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for AMLODIPINE BESYLATE 5 MG TAB has declined 53.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMLODIPINE BESYLATE 5 MG TAB?
Since Nov 28, 2013, the NADAC for AMLODIPINE BESYLATE 5 MG TAB has ranged from a low of $0.0095 (Nov 20, 2024) to a high of $0.0221 (Feb 12, 2014), with a median of $0.0128 per EA.
Are there cheaper alternatives to AMLODIPINE BESYLATE 5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE BESYLATE 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE BESYLATE 5 MG TAB?
AMLODIPINE BESYLATE 5 MG TAB (NDC 76282023890) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.